FeedComing soon.
Featured Posts
Goldman Earnings Sink After Buffett Dividend
Johnson & Johnson's Income Falls 23%
Burberry Shares Leap on Sales UpdateIn The News
- DISH Networks Wins Blockbuster Auction
- What Will Pringles Do for Diamond Foods?
- NYSE Looks at Selling Stakes in Amex Exchange to Drive Volumes
- The Bumpy Ride Continues with Whirlpool
- America Movil to Expand Growth with Pre-Paid Data Plans
- Options Update: Texas Instruments Volatility Flat into National Semi Purchase
- Store Expansion and DIY Activity Will Benefit Lowe's
- OpenTable Gaining Momentum in Diners Seated
- Schwab Acquisition Gives Customers More Options
- Expedia Resumes American Airlines Relationship
- Subscribe
- Subscribe to feed
- Add to My AOL
- Sub with Bloglines
Also on AOL
- Autos
- Technology
- Gaming
- Finance
- Entertainment on AOL
- Lifestyle on AOL
- Travel on AOL
- More on AOL
Last updated: June 19, 2013: 05:49 AM
Hot Stocks
DailyFinance Headlines
- NTRR and Partners Explore the Cutting Edge of $1.7 Billion U.S. Medical Marijuana Sector
- OBJE Gaming App Begins Beta Testing for $86 Billion Market
- TowerJazz to Service High Volume, Commercial Infrared Markets
- JOHNNIE WALKER® BLUE LABEL™ and Alfred Dunhill Unveil Limited Edition Collection in the Face of Resi
- ASCC Explores Potentially Lucrative Sports Sponsoring Opportunities
WalletPop Headlines
- NTRR and Partners Explore the Cutting Edge of $1.7 Billion U.S. Medical Marijuana Sector
- OBJE Gaming App Begins Beta Testing for $86 Billion Market
- TowerJazz to Service High Volume, Commercial Infrared Markets
- JOHNNIE WALKER® BLUE LABEL™ and Alfred Dunhill Unveil Limited Edition Collection in the Face of Resi
- ASCC Explores Potentially Lucrative Sports Sponsoring Opportunities
AOL Business News
- Heat edge Spurs in OT, force Game 7
- Serena's stunning remarks about Ohio rape case
- Yeah, this car is small ... , small,
- Mom, child found in 'slavery' horror
- Major ripoff to avoid here
BioHealth Investor Headlines
- Shouldn’t VIVUS Raise Capital Now? (VVUS)
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
Sponsored Links
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
